Delivery Order SPE2DB20D1100-SPE2DB25FB3L7
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.66 Delivery Order contract is for the supply of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of November 7, 2024. The contract has a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
This federal contract award, with ID SPE2DB20D3101|SPE2DB25FRFH9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,129.57 firm fixed-price delivery order is for the supply of 4567689430 CLINDAMYCIN PHOSPHATE 1% FOAM 100GM, with a completion date of March 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp's Corporate Office division. The $1,130.90 firm-fixed-price delivery order contract has a completion date of May 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $4,744.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of March 3, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Foam, 50 gm. The total ceiling value of the order is $1,077.81. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Clindamycin Phosphate 1% Foam, 100 gm. The contract has a ceiling value of $6,681.59 and an ultimate completion date of April 26, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of clindamycin phosphate 1% foam in 50g units. The contract has a ceiling value of $1,173.91 and a completion date of June 25, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,311.06 firm fixed-price delivery order contract provides for the supply of 4567314907 - CLINDAMYCIN PH 1% GEL 30GM, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565366325 - Clindamycin Phosphate 1% Foam, 50 gm. The order has a firm fixed-price of $2,838.07 and the period of performance runs through August 7, 2024. As a major pharmaceutical distributor, AmerisourceBergen provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies and healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,536.12 Firm Fixed Price Delivery Order contract is for the supply of 4567603857 - CLINDAMYCIN 900 MG/50 ML-D5W 50ML medical products. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...